Status:

COMPLETED

BREast Cancer And Sexuality Treatment

Lead Sponsor:

University of British Columbia

Collaborating Sponsors:

University of Calgary

Conditions:

Sexual Dysfunction

Eligibility:

FEMALE

19+ years

Phase:

NA

Brief Summary

The purpose of this project is to compare the effects of a group mindfulness treatment versus a group sex education on sexual desire, sexual distress, and sexual pain in breast cancer (BrCa) survivors...

Eligibility Criteria

Inclusion

  • Women over the age of majority, with a history of breast cancer and who are at least 3 months following the end of their treatment
  • Fluent in English
  • Exceed the clinical cut-off for sexual distress (Female Sexual Distress Scale).
  • Women who are, and who are not, in a relationship will be eligible as long as they have engaged in sexual activity either alone or with a sexual partner in the past 6 months, or as long as they indicate a willingness to engage in sexual activity (alone or with a sexual partner) during the time period of the study.

Exclusion

  • Active cancer treatment (e.g. chemotherapy or radiation, not including endocrine or maintenance therapies provided they remain constant for the study duration), or scheduled breast reconstruction during the study period.
  • Borderline Personality Disorder or other psychiatric or medical conditions that preclude the ability to fully participate in the group sessions, assessments, and homework.
  • In order to determine whether any changes in symptoms are a result of participation in the intervention, women must also agree to 1) not make changes to or commence vaginal interventions (e.g., topical hormone treatments, vaginal moisturizers, vaginal dilation) or 2) engage in other treatments for sexual difficulties (e.g., sex therapy), for 2 weeks prior to the baseline assessment until 2 weeks following the final intervention session.

Key Trial Info

Start Date :

January 6 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2023

Estimated Enrollment :

118 Patients enrolled

Trial Details

Trial ID

NCT04472104

Start Date

January 6 2020

End Date

April 1 2023

Last Update

May 10 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

UBC Sexual Health Lab, Vancouver Hospital

Vancouver, British Columbia, Canada, V5M 1M9